Clinical Trial Update: Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) [Phase 3]

View source ↗

Summary

Phase 3 results are available for an investigational once-daily nasal spray in adults and adolescents with perennial allergic rhinitis; the trial has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Perennial

Drugs mentioned

• Investigational nasal spray (once-daily)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED | Results posted: 2018-04-13